S5 Ep19: Navigating ESR1 Mutations in HR-Positive Breast Cancer With Dr Wander

Targeted Talks

In this episode of Targeted Talks, Seth Wander, MD, PhD, medical oncologist at Massachusetts General Hospital and assistant professor at Harvard Medical School, discusses the clinical importance of ESR1 mutations in hormone receptor-positive metastatic breast cancer and how these mutations influence treatment approaches.